IL17A and cancer: The above studies suggest that differences in the mode of stimulation have different effects on STAT3 activation; that is, inflammatory stimuli from cytokines, such as IL-17 and IL-22, may activate STAT3 without influencing cancer risk, but oxidative stress, such as UV, may activate STAT3 with increased cancer risk.